AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
Zhanfei Zhang(Sun Yat-sen University), Bi‐Jun Huang(Sun Yat-sen University), Hao Hu(Sun Yat-sen University), Xin‐Ke Zhang(Beijing University of Agriculture), Dong‐Fang Meng(Henan University of Traditional Chinese Medicine), Jing Wang(Sun Yat-sen University), Si‐Ting Lin(Sun Yat-sen University), Yujie Xie(Gaozhou People's Hospital), Fei‐Fei Luo(Sun Yat-sen University), Chao‐Nan Qian(South China Agricultural University), Li‐Xia Peng(Sun Yat-sen University), Tie‐Jun Huang(Shenzhen Second People's Hospital), Chao Cheng(Sun Yat-sen University)
Cited by 23
Related Papers
Mental Health Disorders and Associated Risk Factors in Quarantined Adults During the COVID-19 Outbreak in China: Cross-Sectional Study
|Journal of Medical Internet Research|2020|160
Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against <i>PTEN</i> -null glioblastoma
|Science Advances|2022|141
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
|Cell Reports|2017|129
The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review)
|International Journal of Oncology|2015|128